BriaCell Therapeutics (TSE:BCT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
BriaCell Therapeutics has successfully closed a $5.5 million public offering, selling 7.4 million common shares and accompanying warrants. The company plans to allocate the proceeds toward working capital, corporate purposes, and advancing its business goals. ThinkEquity served as the sole book-running manager for this offering.
For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.
